Artwork

Content provided by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Get To Know Cholangiocarcinoma with Dr. Javle

17:04
 
Distribuie
 

Manage episode 315211779 series 2861129
Content provided by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

As we continue our Cholangiocarcinoma Series I am excited to welcome to the show, Milind Javle, M.D.

Milind Javle is a medical oncologist from Houston, TX. He is currently the Hubert L. and Olive Stringer Professor at UT MD Anderson Cancer Center, he is also the current chair, NCI Task Force, Hepatobiliary Cancers, former chair of the International Cholangiocarcinoma Research Network, Vice President of the Cholangiocarcinoma Foundation: Clinical and Scientific Advisory Board. He graduated from Grant Medical College, Mumbai, India and completed his residency in SUNY, Buffalo, NY, and oncology training at Roswell Park Cancer Institute, NY. He has authored over 200 articles in peer-reviewed literature, has been the principal investigator for several phase 1-3 clinical trials and served in an advisory capacity to pharmaceutical companies, regulatory and networking bodies. He has held leadership positions in the American Society of Clinical Oncology and Hepatobiliary Conventions. He has led/ participated in pivotal clinical trial of infigratinib and ivosidenib which led to FDA approvals and is regarded as one of the international leaders in this field.

Listen in as Dr. Javle helps us Get to know Cholangiocarcinoma.

Learn More About Cholangiocarcinoma At: https://cholangiocarcinoma.org/

Visit http://www.onairadvocate.com for information on all of our products, services & resources.

  continue reading

100 episoade

Artwork
iconDistribuie
 
Manage episode 315211779 series 2861129
Content provided by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

As we continue our Cholangiocarcinoma Series I am excited to welcome to the show, Milind Javle, M.D.

Milind Javle is a medical oncologist from Houston, TX. He is currently the Hubert L. and Olive Stringer Professor at UT MD Anderson Cancer Center, he is also the current chair, NCI Task Force, Hepatobiliary Cancers, former chair of the International Cholangiocarcinoma Research Network, Vice President of the Cholangiocarcinoma Foundation: Clinical and Scientific Advisory Board. He graduated from Grant Medical College, Mumbai, India and completed his residency in SUNY, Buffalo, NY, and oncology training at Roswell Park Cancer Institute, NY. He has authored over 200 articles in peer-reviewed literature, has been the principal investigator for several phase 1-3 clinical trials and served in an advisory capacity to pharmaceutical companies, regulatory and networking bodies. He has held leadership positions in the American Society of Clinical Oncology and Hepatobiliary Conventions. He has led/ participated in pivotal clinical trial of infigratinib and ivosidenib which led to FDA approvals and is regarded as one of the international leaders in this field.

Listen in as Dr. Javle helps us Get to know Cholangiocarcinoma.

Learn More About Cholangiocarcinoma At: https://cholangiocarcinoma.org/

Visit http://www.onairadvocate.com for information on all of our products, services & resources.

  continue reading

100 episoade

Alle episoder

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință